It therefore remains to be elucidated whether PrRP31 analogues mediate their metabolic effects through GPR10, NPFF2R or dual GPR10-NPFF2R stimulation explains the potent anti-obesity efficacy of this compound class. This evidence concerns the gene PRLHR and obesity disorder.